LONDON, Nov. 18, 2021 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “ Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that Mr. Paul Maier has been appointed as a non-executive independent director of the board of directors of the Company (the “Board”). He will hold office as an independent director until the…


Previous articleEyes on Oregon, a Psychedelics Today Podcast with Jon Dennis and Joe Moore
Next articleAlgernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study